[Pharmacodynamics and pharmacokinetics of therapeutic osmoregulating agents in increased intracranial pressure].
Prange
H W
HW
Nau
R
R
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000502:physiology; D004234:Diuretics, Osmotic / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D005990:Glycerol / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D006801:Humans; D019586:Intracranial Hypertension / Q000097:blood* / Q000188:drug therapy / Q000209:etiology; D008353:Mannitol / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D013012:Sorbitol / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D016896:Treatment Outcome; D014882:Water-Electrolyte Balance / Q000187:drug effects* / Q000502:physiology
D004234:Diuretics, Osmotic; D012462:Saline Solution, Hypertonic; D008353:Mannitol; D013012:Sorbitol; D005990:Glycerol